Goldman Sachs Assumes Cytokinetics (CYTK) at Buy

January 28, 2022 2:44 AM EST
Get Alerts CYTK Hot Sheet
Price: $39.04 +0.75%

Rating Summary:
    17 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 14 | Down: 21 | New: 12
Trade Now! 
Join SI Premium – FREE

Goldman Sachs analyst Madhu Kumar assumes coverage on Cytokinetics (NASDAQ: CYTK) with a Buy rating and a price target of $74.00.


For an analyst ratings summary and ratings history on Cytokinetics click here. For more ratings news on Cytokinetics click here.


Shares of Cytokinetics closed at $29.74 yesterday.


You May Also Be Interested In





Related Categories

New Coverage